Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
Part of paid clinical trials in Charlotte, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT05129345
- Status
- Recruiting
Conditions
- Dyslipidemias
- HIV-1-infection
- Hypertension
- Type 2 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals. Aim 2: Assess PLWH knowledge, skills, and confidence for self-management of cardiometabolic disorders. Aim 3: Tailor a self-management support and education intervention with stakeholder input to address barriers to achieving treatment goals for cardiometabolic disorders in PLWH at the study sites.
Key Dates
- Start date
- Jun 7, 2022
- Status verified
- Jul 2025
- Primary completion
- Oct 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Aim 1People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes. All genders, races and ethnicities will be included in this study. Subjects will have a telephone visit including being consented electronically and complete a demographic survey, a photography training visit and an interview visit.
- Arm: Aim 2People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes. All genders, races and ethnicities will be included in this study. Subjects will have a telephone visit and be electronically consented to study and complete an electronic survey.
- Arm: Aim 3Group composed of 10 willing participants recruited from the participating clinics and community based organizations and may include, HIV providers, nurses, pharmacists, people living with HIV who have cardiometabolic disorders, and representatives of the community advisory boards, and any other key stakeholders. There will be 3 one hour meetings over 3 months.
Primary Outcome Measure
Aim 1: Number of social determinants of cardiometabolic health identified from interviews [ Time Frame: 2 weeks after enrollment ]
Central Contacts
- Stuart T Carr, BA919 668-4849
- Charles Muiruri, PhD919 660-3212
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University - Charlotte Study Sites | Charlotte | North Carolina | 28205 | |
| Duke University - Duke Study Site | Durham | North Carolina | 27710 |
Find similar trials in Charlotte, NC
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes MellitusNot Yet Recruiting · Bionime Corporation · Guntersville, Alabama